Beat C Bornhauser

19PUBLICATIONS

156CO-AUTHORS

Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|May 06, 2026

TCF3::HLF orchestrates an enhancer-promoter network with activation of MEF2C to promote immature HSC gene expression in leukemia.

|Mar 27, 2026

IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Sonja Bendig, Alina M Hartmann, Wiebke Wessels

|Sep 10, 2025

A three-dimensional ex vivo model recapitulates in vivo features and drug resistance phenotypes in childhood acute lymphoblastic leukemia.

Magdalini Kanari, Iria Jimenez Garcia, Fabio D Steffen

|Jun 27, 2025

Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia.

Julia Costea, Kerstin K Rauwolf, Pietro Zafferani

|May 19, 2025

Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12.

Selina Troester, Thomas Eder, Nadja Wukowits

|May 13, 2025

Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia.

Anna Saorin, Anna Dehler, Bartimée Galvan

Pageof 4

Frequent Collaborators

Jean-Pierre Bourquin

Fabio Daniel Steffen

Tobias Rausch

Andreas E Kulozik

Jan O Korbel

Denis Schewe

James Kim

Bartimée Galvan

Samanta Kisele

Luca L Fava

Frequent Collaborators

Jean-Pierre Bourquin

Fabio Daniel Steffen

Tobias Rausch

Andreas E Kulozik